The global women’s health market was valued at USD 53.90 Billion in 2025, driven by the increasing awareness and focus on women-specific diseases and the growing adoption of advanced diagnostic and therapeutic technologies across the globe. The market is anticipated to grow at a CAGR of 5.20% during the forecast period of 2026-2035, with the values likely to reach USD 89.48 Billion by 2035. The market growth is driven by expanding healthcare infrastructure and increasing investments in women’s health research. The rising demand for personalized treatments and advancements in digital health solutions further contribute to market growth during the forecast period.
Base Year
Historical Period
Forecast Period
Polycystic ovary syndrome (PCOS) affects 6-13% of reproductive-aged women, with up to 70% undiagnosed globally, according to the World Health Organization. This growing burden is fueling demand for diagnostics and treatments, driving significant growth in the market.
In February 2024, Johns Hopkins launched the Center for Global Women’s Health and Gender Equity to advance research and training on gender equality. This initiative is expected to drive market growth by fostering innovation and empowering women-focused healthcare solutions.
A key trend in the global women’s health market is the rise of digital health advocacy to boost awareness and engagement. For instance, in April 2025, FIGO launched a global social ambassador program to support women’s health online.
Compound Annual Growth Rate
5.2%
Value in USD Billion
2026-2035
*this image is indicative*
Women’s health focuses on the diagnosis, treatment, and prevention of conditions unique to females, including reproductive, hormonal, and gynecological health, as well as general wellness across different life stages. The market is driven by rising awareness, increasing healthcare access, and advancements in medical technologies. It encompasses a broad range of services, products, and therapies addressing female-specific needs, from fertility to menopause. The market is poised to grow at a CAGR of 5.20% during the forecast period of 2026–2035, supported by ongoing research, favorable government initiatives, and a growing emphasis on personalized and preventive healthcare for women.
Innovative Global Initiatives to Accelerate the Growth in the Market
The increasing implementation of global health initiatives targeting underserved populations is a major driver of growth in the women’s health market. For example, in October 2024, UNFPA launched the WomenX Collective during the World Health Summit in Berlin. This groundbreaking initiative aims to improve reproductive and maternal health in low- and middle-income countries by establishing innovation hubs, beginning in Berlin and expanding to Nairobi by 2025. With a USD 100 million investment goal by 2030 and support from key international donors, the initiative is expected to strengthen access to healthcare and significantly boost the women’s health market worldwide.
The market is experiencing several key trends, including an increasing global focus on women’s health and growing investment in the sector.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Drug Class
Market Breakup by Application
Market Breakup by Age Group
Market Breakup by Region
Fertility Agents to Lead the Segmentation by Drug Class
Reproductive health and contraception are projected to lead the global women’s health market, significantly shaping its growth trajectory. Increasing adoption of modern contraceptives has enhanced preventive care, reduced healthcare costs, and improved maternal and child health outcomes. According to 2024 Family Planning data, 380 million women and girls in low- and lower-middle-income countries now use modern contraception, helping prevent 143 million unintended pregnancies, 144,000 maternal deaths, and 29 million unsafe abortions from July 2023 to July 2024. This surge underscores growing investment and innovation in reproductive health. Other key segments include menopause, osteoporosis, cancer, urology, and others.
The market report covers several regions including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Among these, North America is anticipated to maintain a leading position due to its advanced healthcare infrastructure, high patient awareness, supportive regulatory environment, and rapid adoption of innovative medical technologies. For example, in 2024, ConTIPI Medical, in partnership with Eversana, successfully launched ProVate in the United States. This disposable, non-surgical device addresses pelvic organ prolapse and offers women a convenient, at-home treatment option, reflecting the region’s emphasis on patient-centered care and technological advancement.
The key features of the market report comprise patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
AbbVie, Inc., headquartered in North Chicago, Illinois, was established in 2013. Through its Allergan Aesthetics division, AbbVie offers advanced products in women's health, including facial injectables and skin care treatments. In 2024, AbbVie, along with SkinSpirit, a leading medical aesthetics provider founded in 2002, strengthened their market presence by supporting women’s empowerment initiatives, reflecting their commitment to innovation and leadership in women’s health.
Established in 1923 with headquarters in Jersey City, New Jersey, Organon is a global healthcare company dedicated to women’s health. In 2024, it entered a licensing agreement with Bao Pharmaceutical to commercialize SJ02, an innovative long-acting follicle-stimulating hormone for assisted reproductive technology in China. This advances Organon’s commitment to expanding fertility treatment options worldwide.
Pfizer, Inc., headquartered in New York City and established in 1850, plays a significant role in the global women’s health market through impactful initiatives. In January 2025, the Pfizer Foundation committed USD 15 million to improve breast cancer care in Sub-Saharan Africa. This investment supports programs focused on early diagnosis, accelerating treatment access, and overcoming healthcare barriers, reflecting Pfizer’s strong dedication to advancing women’s health and promoting global health equity.
Headquartered in London, United Kingdom, Theramex is a leading global pharmaceutical company dedicated exclusively to women’s health. In December 2024, the European Commission approved an extended indication for its oral gonadotropin-releasing hormone (GnRH) antagonist, Yselty (linzagolix), to treat symptomatic endometriosis in adult women with a history of previous medical or surgical treatment. This approval reinforces Theramex’s commitment to developing innovative and effective therapies across key areas such as contraception, fertility, menopause, and osteoporosis, aiming to improve the quality of life for women worldwide.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Bayer AG, Agile Therapeutics, Amgen, Inc., Apothecus Pharmaceutical Corp., Blairex Laboratories, Inc., and Ferring.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Class |
|
| Breakup by Application |
|
| Breakup by Age Group |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share